PHARMACOECONOMICS

Scope & Guideline

Advancing understanding of drug costs and health outcomes.

Introduction

Immerse yourself in the scholarly insights of PHARMACOECONOMICS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1170-7690
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1992 to 2024
AbbreviationPHARMACOECONOMICS / Pharmacoeconomics
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The journal 'PHARMACOECONOMICS' focuses on the economic evaluation of health technologies, aiming to inform healthcare decision-making through rigorous analysis and modeling. It emphasizes the integration of clinical effectiveness with economic implications, encouraging a multidisciplinary approach that encompasses health policy, pharmacoeconomics, and public health.
  1. Economic Evaluation of Health Technologies:
    The journal publishes studies that evaluate the cost-effectiveness of various health interventions, including pharmaceuticals, medical devices, and healthcare services, using methodologies such as cost-utility analysis, cost-effectiveness analysis, and budget impact analysis.
  2. Modeling Approaches in Health Economics:
    A significant focus is on the development and application of various modeling techniques, including Markov models, discrete event simulation, and probabilistic modeling, to assess long-term outcomes and economic impacts of health interventions.
  3. Patient-Centered Outcomes and Quality of Life:
    Research related to the measurement of health-related quality of life (HRQoL) and patient preferences is prominent. This includes studies on utility measures like EQ-5D and their application in economic evaluations.
  4. Real-World Evidence and Data Utilization:
    The journal encourages the use of real-world data to inform economic evaluations and policy decisions, emphasizing the relevance of real-world evidence in assessing the economic impact of interventions.
  5. Interdisciplinary Approaches to Health Economics:
    It promotes an interdisciplinary perspective, integrating insights from clinical research, epidemiology, health policy, and behavioral economics to enhance the depth and applicability of economic evaluations.
The journal 'PHARMACOECONOMICS' is adapting to contemporary healthcare challenges and evolving research methodologies. Recent publications indicate a strong focus on innovative approaches and emerging themes in health economics.
  1. Value-Based Healthcare and Pricing Models:
    There is a growing emphasis on value-based healthcare frameworks that assess the value of interventions in terms of outcomes relative to costs. This trend reflects the shift towards outcome-oriented pricing models in the healthcare industry.
  2. Equity and Social Determinants of Health:
    Research addressing health equity and the social determinants of health is gaining traction, emphasizing the importance of considering how economic evaluations can impact diverse populations and promote equitable healthcare access.
  3. Integration of Real-World Data:
    The use of real-world data in economic evaluations is on the rise, highlighting the importance of incorporating actual patient outcomes and resource utilization into cost-effectiveness analyses.
  4. Patient and Stakeholder Engagement:
    There is an increasing focus on involving patients and stakeholders in the economic evaluation process to better capture preferences and improve the relevance of health technologies to end-users.
  5. Innovative Methodological Approaches:
    Emerging methodologies, such as machine learning and advanced statistical techniques, are being applied to economic evaluations, enhancing the robustness and precision of analyses in complex healthcare environments.

Declining or Waning

While the journal continues to thrive in various areas, certain themes have shown a decline in prominence over recent years. This shift may reflect changing priorities in health economics and emerging challenges in the healthcare landscape.
  1. Traditional Cost-Effectiveness Analysis:
    There is a noticeable reduction in studies solely focused on traditional cost-effectiveness analysis without considering broader implications, such as equity or long-term societal impacts. This indicates a shift towards more comprehensive evaluation frameworks.
  2. Pharmacoeconomic Evaluations of Older Therapies:
    Research on older therapies appears to be declining as newer, more innovative treatments emerge. The focus is shifting towards assessing the economic impact of cutting-edge therapies and technologies rather than established treatments.
  3. Narrowly Focused Economic Models:
    The journal has seen fewer publications that rely on narrowly focused economic models with limited scope. There is now a trend towards more complex models that account for a variety of factors, including patient heterogeneity and real-world complexities.
  4. Sole Emphasis on Cost Minimization:
    Papers that primarily focus on cost minimization strategies without addressing the broader implications for health outcomes and quality of life are becoming less frequent, as the field moves towards more holistic evaluations.
  5. Regional Studies with Limited Generalizability:
    There is a waning interest in studies that focus exclusively on localized economic evaluations without consideration for broader applicability or generalizability to other settings or populations.

Similar Journals

HEALTH SERVICES RESEARCH

Leading the way in health policy and services research.
Publisher: WILEYISSN: 0017-9124Frequency: 6 issues/year

HEALTH SERVICES RESEARCH, published by Wiley, is a premier journal focused on advancing the field of health policy and services research. With an ISSN of 0017-9124 and an impressive E-ISSN of 1475-6773, this esteemed publication has been at the forefront of health services inquiry since its inception in 1966. Recognized as a Q1 journal in Health Policy for 2023, it ranks #80 out of 310 in Scopus, placing it in the 74th percentile, underlining its significant influence in the field. The journal caters to a global audience of researchers, practitioners, and students by providing a platform for rigorous empirical studies and critical reviews that aim to improve health care delivery and policy outcomes. Although it does not offer open access, the comprehensive articles and insights published within its pages are essential for anyone seeking to understand and influence health systems. With its convergence towards the year 2024, HEALTH SERVICES RESEARCH continues to be a vital resource for those dedicated to enhancing healthcare effectiveness and accessibility.

International Journal of Health Economics and Management

Empowering research to transform health management practices.
Publisher: SPRINGERISSN: 2199-9023Frequency: 4 issues/year

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.

International Journal of Clinical Pharmacy

Advancing Clinical Pharmacy Knowledge for Global Impact
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Pioneering assessments that redefine health technology landscapes.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0266-4623Frequency: 1 issue/year

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE is a leading academic journal published by Cambridge University Press, specializing in the critical evaluation of healthcare technologies and their impact on health policy. Established in 1970, it has gained recognition within the field, currently holding a prestigious Q2 ranking in Health Policy, with a commendable position of #89 out of 310 in the Scopus rankings, placing it in the 71st percentile. The journal serves as an essential platform for researchers, professionals, and students interested in the intersection of technology and health care, facilitating the dissemination of innovative research findings and practical assessments that inform policy-making and improve health outcomes. With a focus on advancing knowledge from 1985 to 2024, the journal's content remains relevant and impactful. Though not open access, it offers subscription-based access to a wealth of articles that contribute to shaping the future of healthcare technology assessment.

Applied Health Economics and Health Policy

Exploring the nexus of health policy and economic impact.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Gesundheitsoekonomie und Qualitaetsmanagement

Exploring the Intersection of Healthcare Economics and Quality
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

Journal of the American College of Clinical Pharmacy

Fostering collaboration in the pursuit of pharmaceutical advancements.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

International Journal of Healthcare Management

Pioneering research for a healthier tomorrow.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2047-9700Frequency: 4 issues/year

The International Journal of Healthcare Management, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, stands as a crucial platform for the dissemination of innovative research and insights in the realm of healthcare management. With a focus on health policy, leadership, and management, this journal aims to bridge the gap between theory and practice, providing a valuable resource for researchers, professionals, and students alike. It boasts an impressive Q2 ranking in Leadership and Management and a Q3 ranking in Health Policy for 2023, highlighting its influence and relevance within the academic community. With an accessible ISSN of 2047-9700 and E-ISSN of 2047-9719, the journal features an array of peer-reviewed articles that promote the advancement of knowledge and best practices in healthcare settings. While currently not offered as open access, the journal publishes high-quality research that underscores the importance of effective management strategies in enhancing healthcare outcomes. Positioned in the United Kingdom, the journal continues to contribute significant knowledge and frameworks that guide healthcare leaders and policymakers in navigating the complexities of governance in health services.

Pharmacoeconomics-Open

Transforming Healthcare Through Collaborative Scholarship
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

Health Economics Review

Transforming health policy through innovative research.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.